195 related articles for article (PubMed ID: 14566202)
1. Paroxetine treatment of generalized anxiety disorder.
Sheehan DV; Mao CG
Psychopharmacol Bull; 2003; 37 Suppl 1():64-75. PubMed ID: 14566202
[TBL] [Abstract][Full Text] [Related]
2. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
[TBL] [Abstract][Full Text] [Related]
3. Treatment of panic disorder: focus on paroxetine.
Pollack MH; Doyle AC
Psychopharmacol Bull; 2003; 37 Suppl 1():53-63. PubMed ID: 14566201
[TBL] [Abstract][Full Text] [Related]
4. Paroxetine: an update of its use in psychiatric disorders in adults.
Wagstaff AJ; Cheer SM; Matheson AJ; Ormrod D; Goa KL
Drugs; 2002; 62(4):655-703. PubMed ID: 11893234
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of controlled-release paroxetine.
Golden RN
Psychopharmacol Bull; 2003; 37 Suppl 1():176-86. PubMed ID: 14566210
[TBL] [Abstract][Full Text] [Related]
6. Changes on the Temperament and Character Inventory after paroxetine treatment in volunteers with generalized anxiety disorder.
Allgulander C; Cloninger CR; Przybeck TR; Brandt L
Psychopharmacol Bull; 1998; 34(2):165-6. PubMed ID: 9640994
[TBL] [Abstract][Full Text] [Related]
7. Spotlight on paroxetine in psychiatric disorders in adults.
Wagstaff AJ; Cheer SM; Matheson AJ; Ormrod D; Goa KL
CNS Drugs; 2002; 16(6):425-34. PubMed ID: 12027788
[TBL] [Abstract][Full Text] [Related]
8. In vivo neuroimaging correlates of the efficacy of paroxetine in the treatment of mood and anxiety disorders.
Kilts C
Psychopharmacol Bull; 2003; 37 Suppl 1():19-28. PubMed ID: 14566198
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Venlafaxine ER in patients with social anxiety disorder: a double-blind, placebo-controlled, parallel-group comparison with paroxetine.
Allgulander C; Mangano R; Zhang J; Dahl AA; Lepola U; Sjödin I; Emilien G;
Hum Psychopharmacol; 2004 Aug; 19(6):387-96. PubMed ID: 15303242
[TBL] [Abstract][Full Text] [Related]
10. Paroxetine: a review of clinical experience.
Dunner D; Kumar R
Pharmacopsychiatry; 1998 May; 31(3):89-101. PubMed ID: 9657236
[TBL] [Abstract][Full Text] [Related]
11. Paroxetine in the treatment of generalised anxiety disorder.
Snyderman SH; Rynn MA; Bellew K; Rickels K
Expert Opin Pharmacother; 2004 Aug; 5(8):1799-806. PubMed ID: 15264994
[TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapy of social anxiety disorder: what does the evidence tell us?
Davidson JR
J Clin Psychiatry; 2006; 67 Suppl 12():20-6. PubMed ID: 17092192
[TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy of generalized anxiety disorder.
Davidson JR
J Clin Psychiatry; 2001; 62 Suppl 11():46-50; discussion 51-2. PubMed ID: 11414551
[TBL] [Abstract][Full Text] [Related]
14. Paroxetine treatment of mood and anxiety disorders in children and adolescents.
Wagner KD
Psychopharmacol Bull; 2003; 37 Suppl 1():167-75. PubMed ID: 14566209
[TBL] [Abstract][Full Text] [Related]
15. Generalized anxiety disorder: how to treat, and for how long?
Lam RW
Int J Psychiatry Clin Pract; 2006; 10 Suppl 1():10-5. PubMed ID: 24931538
[TBL] [Abstract][Full Text] [Related]
16. [Actual therapeutic options in the treatment of generalized anxiety disorders].
Delini-Stula A; Bondolfi G; Holsboer-Trachsler E
Rev Med Suisse; 2010 Jun; 6(255):1370-4. PubMed ID: 20684132
[TBL] [Abstract][Full Text] [Related]
17. Long-term goals in the management of acute and chronic anxiety disorders.
Kjernisted KD; Bleau P
Can J Psychiatry; 2004 Mar; 49(3 Suppl 1):51S-63S. PubMed ID: 15147036
[TBL] [Abstract][Full Text] [Related]
18. Treatment of anxiety disorders with venlafaxine XR.
Thase ME
Expert Rev Neurother; 2006 Mar; 6(3):269-82. PubMed ID: 16533131
[TBL] [Abstract][Full Text] [Related]
19. Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder.
Bose A; Korotzer A; Gommoll C; Li D
Depress Anxiety; 2008; 25(10):854-61. PubMed ID: 18050245
[TBL] [Abstract][Full Text] [Related]
20. Paroxetine treatment of mood disorders in women: premenstrual dysphoric disorder and hot flashes.
Yonkers KA
Psychopharmacol Bull; 2003; 37 Suppl 1():135-47. PubMed ID: 14566208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
